Shares of Amarin AMRN are higher on the session by 8.64%, currently trading at $13.20. The stock has been moving largely higher over the past few days and is currently testing the 50-day moving average.
Options traders are buying calls on the name today. A short while ago the September 2011 $20.00 call traded 19,000 times on open interest of 32,688 contracts.
Overall call volume is now running at 7.18x the daily average with 77% of all calls traded being purchases on the offer.
Amarin Corporation plc is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in